
[1] FDA NDA 202155/S-003 (March 13, 2014).
[2] FDA News Release "FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation," (December 28, 2012).
Sign-up to receive recall notices, medical news, and litigation updates.